Global Cooperation Feasibility Studies

点击翻译按钮获取中文摘要

1 in 5 of us experience mental health problems during our lifetime but more than 50% of patients don’t receiveadequate care when assessed using current methods - leading to risk of further deterioration in well-being,reduction in quality of life, loss of income, family breakdown, and self-harming. SaccScan is a novel point-of-care (PoC) software diagnostic system which has been demonstrated to detect schizophrenia with better than95% accuracy and has been extended with the same precision to bipolar disorder and major depressionillnesses. The software diagnostic tool successfully utilises eye-movement abnormalities as clinical diagnosticbiomarkers for serious mental illnesses. The test can be performed within 30 minutes and results producedover the internet at near real-time speed. The purpose of this study is to explore international partnerships forbringing a minimum viable version of the test to market and address the global challenge of improvingtreatment outcomes through personalising medicine in mental health care.